UW School of Medicine and Public Health
Madison, Wisconsin, 53792, United States
NCT Number: NCT07520955
This study is to evaluate the effectiveness of targeted Transcranial Electrical Stimulation with Temporal Interference (TES-TI) interventions to boost Non-Rapid Eye Movement (NREM) sleep, decrease seizures and promote emotional health in patients with epilepsy. Up to 24 participants (8 control participants for technical optimization prior to recruitment and 16 patients with epilepsy) will be enrolled and can expect to be on study for up to 24 months.
Trial opening soon.
Get Notified18 year–75 year
All sexes
Interventional
Not applicable
Madison, Wisconsin, 53792, United States
This is a Phase I randomized, single-blind, cross-over feasibility study comprised of 16 participants. Each participant will undergo structural and functional MRI then complete four nights of TES-TI stimulation and four nights of sham stimulation in counterbalanced order, separated by ≥1 day between visits.
Conditions on each visit are randomized and counterbalanced. During each visit, participants will complete both the REST-Q and SSS questionnaires. Full HD-EEG will be applied as well as 4-16 stimulation electrodes. Participants will then undergo an emotion regulation task (face task) wherein they are presented with positive, negative, or neutral emotional stimuli.
This is followed by a resting HD-EEG recording, then overnight stimulation. Either sham or non-sham (8 patients in each group) stimuli will be applied at times during the sleep period. Upon waking, the same questionnaires and emotion regulation tasks will be completed.
Objectives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Real stimulation will take place on visits 2 - 5 or visits 6 - 10.
Other names: Transcranial Electrical Stimulation with Temporal Interference
Sham stimulation will take place on visits 2 - 5 or visits 6 - 10.
After baseline night visit 1 and before intervention visits 2 - 10. MRI is used to help determine electrode placement.
Other names: EEG-fMRI, anatomic MRI
Time frame: measured during 8 overnight visits, data collected up to 24 months on study
To assess the effect of TES-TI on NREM sleep slow-wave activity during treatment (4 nights) vs. sham (4 nights), slow-wave activity will be measured by high-density EEG.
Time frame: data collected at 4 time points up to 24 months on study, 1 month and 3 month follow up after completion of 4 nights treatment and 1 month and 3 month follow up after completion 4 nights sham condition
To assess the effect of TES-TI on incidence of seizures after treatment (4 nights) vs. sham (4 nights), participants will maintain a seizure diary. The self-reported number of seizures seizures per week for the first week and the first four-weeks post-intervention.
Time frame: measured during 8 overnight visits, data collected up to 24 months on study
The vigilance task will be used to assess the effect of TES-TI on performance after treatment (4 nights) vs. sham (4 nights). This is a computerized reaction time task where a participant is presented with a fixation point on a computer screen. At random, the fixation point will change appearance at which point the participant is to click a provided button as quickly as possible. The time it took to respond is recorded automatically by the computer program and will be reported as the result.
Time frame: measured during 8 overnight visits, data collected up to 24 months on study
The REST-Q measure will be used to assess the effect of TES-TI on sleep quality and mood after treatment (4 nights) vs. sham (4 nights). It is a 9-item questionnaire assessing aspects of restorative sleep. Each item is scored on a 5-point Likert scale (1-light; 5-deep). Final scores are transformed to a scale of 0-100 here higher scores indicate more restorative sleep.
Time frame: measured during 8 overnight visits, data collected up to 24 months on study
The Stanford Sleepiness Scale will be used to assess sleepiness after treatment (4 nights) vs. sham (4 nights). SSS is a measure of subjective alertness on a 7-point scale (total range of scores from 1-7). A lower score on the scale indicates higher alertness.
Time frame: measured during 8 overnight visits, data collected up to 24 months on study
The Face Task will be used to assess the effect of TES-TI on emotion response after treatment (4 nights) vs. sham (4 nights). This task involves viewing a series of emotionally charged images (60 positive, 60 negative, 60 neutral).
Time frame: measured during 8 overnight visits, data collected up to 24 months on study
The Face Task will be used to assess the effect of TES-TI on emotion response after treatment (4 nights) vs. sham (4 nights). This task involves viewing a series of emotionally charged images (60 positive, 60 negative, 60 neutral).
Contact information is provided by the study sponsor or research team.
Beril Mat, MD
CONTACT
Melanie Boly, MD, PhD
CONTACT
University of Wisconsin, Madison
Other
Using Temporal Interference to Non-Invasively Enhance Sleep Homeostasis in Patients With Epilepsy
Acronym: SLEEP-TIES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735715
Brain Diseases, Central Nervous System Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT07721272
Brain Diseases, Central Nervous System Diseases
Dallas, Texas, United States
View Trial DetailsNCT07680322
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT06534502
Brain Diseases, Central Nervous System Diseases
Winston-Salem, North Carolina, United States
View Trial Details